Novartis AG
FGF21 mimetic antibodies and uses thereof
Last updated:
Abstract:
The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human .beta.-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Status:
Grant
Type:
Utility
Filling date:
6 Feb 2018
Issue date:
26 Jan 2021